FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 48 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,382 | -18.1% | 18,783 | 0.0% | 0.00% | – |
| Q4 2022 | $9,016 | -71.8% | 18,783 | 0.0% | 0.00% | – |
| Q3 2022 | $32,000 | -65.6% | 18,783 | -42.3% | 0.00% | – |
| Q2 2022 | $93,000 | -66.4% | 32,574 | -40.7% | 0.00% | – |
| Q1 2022 | $277,000 | -51.9% | 54,950 | -4.8% | 0.00% | – |
| Q4 2021 | $576,000 | -17.4% | 57,711 | +7.7% | 0.00% | – |
| Q3 2021 | $697,000 | +0.3% | 53,579 | +8.5% | 0.00% | – |
| Q2 2021 | $695,000 | – | 49,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |